KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolent Health (EVH) EPS (Weighted Average and Diluted) (2016 - 2025)

Evolent Health (EVH) has 11 years of EPS (Weighted Average and Diluted) data on record, last reported at -$0.24 in Q3 2025.

  • For Q3 2025, EPS (Weighted Average and Diluted) rose 11.11% year-over-year to -$0.24; the TTM value through Sep 2025 reached -$1.57, down 70.65%, while the annual FY2024 figure was -$0.81, 36.72% up from the prior year.
  • EPS (Weighted Average and Diluted) reached -$0.24 in Q3 2025 per EVH's latest filing, up from -$0.44 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.02 in Q3 2022 and bottomed at -$0.63 in Q1 2025.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.21, with a median of -$0.22 recorded in 2024.
  • Peak YoY movement for EPS (Weighted Average and Diluted): skyrocketed 113.33% in 2022, then tumbled 1550.0% in 2023.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.07 in 2021, then crashed by 67.65% to -$0.11 in 2022, then crashed by 236.36% to -$0.37 in 2023, then increased by 29.73% to -$0.26 in 2024, then grew by 7.69% to -$0.24 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Weighted Average and Diluted) were -$0.24 in Q3 2025, -$0.44 in Q2 2025, and -$0.63 in Q1 2025.